About Charged multivesicular body protein 7
Charged multivesicular body protein 7 (CHMP7) is a protein
from Homo sapiens identified by UniProt accession
Q8WUX9, 453 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Charged multivesicular body protein 7 |
| UniProt accession | Q8WUX9 |
| Gene | CHMP7 |
| Organism | Homo sapiens |
| Length | 453 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.49
- viral disease · score 0.46
- HIV infection · score 0.46
- COVID-19 · score 0.37
- severe acute respiratory syndrome · score 0.37
- cortical surface area measurement · score 0.21
- brain measurement · score 0.21
- cortical thickness · score 0.21
- breast adenocarcinoma · score 0.18
- blood protein measurement · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WUX9-F1 | alphafold | PREDICTED | 76.01 | — |
Amino-acid sequence (453 residues)
MWSPEREAEA PAGGDPAGLL PPEWEEDEER MSFLFSAFKR SREVNSTDWD SKMGFWAPLV LSHSRRQGVV RLRLRDLQEA FQRKGSVPLG LATVLQDLLR RGELQRESDF MASVDSSWIS WGVGVFLLKP LKWTLSNMLG DNKVPAEEVL VAVELLKEKA EEVYRLYQNS PLSSHPVVAL SELSTLCANS CPDERTFYLV LLQLQKEKRV TVLEQNGEKI VKFARGPRAK VSPVNDVDVG VYQLMQSEQL LSRKVESLSQ EAERCKEEAR RACRAGKKQL ALRSLKAKQR TEKRIEALHA KLDTVQGILD RIYASQTDQM VFNAYQAGVG ALKLSMKDVT VEKAESLVDQ IQELCDTQDE VSQTLAGGVT NGLDFDSEEL EKELDILLQD TTKEPLDLPD NPRNRHFTNS VPNPRISDAE LEAELEKLSL SEGGLVPSSK SPKRQLEPTL KPL
Explore Charged multivesicular body protein 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets